Reducing High Risk Primary Tumor Clinical Target Volumes (CTVp1) in Non-metastatic Nasopharyngeal Carcinoma

NARecruitingINTERVENTIONAL
Enrollment

454

Participants

Timeline

Start Date

August 4, 2023

Primary Completion Date

August 4, 2026

Study Completion Date

September 1, 2029

Conditions
Nasopharyngeal CarcinomaIntensity-Modulated Radiotherapy
Interventions
RADIATION

Reduction CTVp1

High Risk Primary Tumor Clinical Target Volumes (CTVp1) is defined as 5mm margin from GTVp,including pre-induction chemotherapy tumor extension( CTVp1=GTVp+5mm)

RADIATION

Non-reduction CTVp1

High Risk Primary Tumor Clinical Target Volumes (CTVp1) is defined as whole nasopharynx as well as 5mm margin from GTVp( CTVp1=GTVp+5mm+whole nasopharynx)

Trial Locations (1)

528403

RECRUITING

Zhongshan City People's Hospital, Zhongshan

All Listed Sponsors
collaborator

Sun Yat-sen University Cancer Centre

UNKNOWN

lead

Zhongshan People's Hospital, Guangdong, China

OTHER